Pancreatic Cancer: New Therapy Erases Precancerous Cells
Precision Interception: How Targeting Precancerous Cells Could Rewrite the Future of Pancreatic Cancer Pancreatic cancer, a disease notorious for its late-stage diagnosis and aggressive nature, currently has a five-year survival rate of just 11%. But a paradigm shift is brewing. Recent breakthroughs, including experimental therapies demonstrating the elimination of precancerous cells in mice, suggest a … Read more